Imai Kohsuke, Slupphaug Geir, Lee Wen-I, Revy Patrick, Nonoyama Shigeaki, Catalan Nadia, Yel Leman, Forveille Monique, Kavli Bodil, Krokan Hans E, Ochs Hans D, Fischer Alain, Durandy Anne
Institut National de la Santé et de la Recherche Médicale Unité 429, Hôpital Necker-Enfants Malades, 75015 Paris, France.
Nat Immunol. 2003 Oct;4(10):1023-8. doi: 10.1038/ni974. Epub 2003 Sep 7.
Activation-induced cytidine deaminase (AID) is a 'master molecule' in immunoglobulin (Ig) class-switch recombination (CSR) and somatic hypermutation (SHM) generation, AID deficiencies are associated with hyper-IgM phenotypes in humans and mice. We show here that recessive mutations of the gene encoding uracil-DNA glycosylase (UNG) are associated with profound impairment in CSR at a DNA precleavage step and with a partial disturbance of the SHM pattern in three patients with hyper-IgM syndrome. Together with the finding that nuclear UNG expression was induced in activated B cells, these data support a model of CSR and SHM in which AID deaminates cytosine into uracil in targeted DNA (immunoglobulin switch or variable regions), followed by uracil removal by UNG.
活化诱导的胞苷脱氨酶(AID)是免疫球蛋白(Ig)类别转换重组(CSR)和体细胞高频突变(SHM)产生过程中的“关键分子”,AID缺陷与人类和小鼠的高IgM表型相关。我们在此表明,编码尿嘧啶-DNA糖基化酶(UNG)的基因的隐性突变与三名高IgM综合征患者在DNA预切割步骤的CSR严重受损以及SHM模式的部分紊乱有关。连同在活化B细胞中诱导核UNG表达这一发现,这些数据支持了一种CSR和SHM模型,即AID将靶向DNA(免疫球蛋白转换或可变区)中的胞嘧啶脱氨为尿嘧啶,随后由UNG去除尿嘧啶。